DOTA-GA(tBu)4, CAS [[306776-79-4]]

Produktübersicht

• Artikelname: DOTA-GA(tBu)4, CAS [[306776-79-4]]
• Artikelnummer: MCE-HY-W614269
• Hersteller Artikelnummer: HY-W614269
• Alternativnummer: MCE-HY-W614269-50MG,MCE-HY-W614269-10MMX1ML,MCE-HY-W614269-25MG,MCE-HY-W614269-10MG,MCE-HY-W614269-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DOTA-GA(tBu)4 stabilizes the attachment of radiometals to ligands. DOTA-GA(tBu)4 improves the biodistribution of radiolabeled second-generation Affibody molecules by increasing their net negative charge and reducing hepatic uptake, leading to enhanced tumor-to-blood and tumor-to-liver ratios. DOTA-GA(tBu)4 targets HER2-expressing breast and gastrointestinal cancer. [1][2]

Produkteigenschaften

• Molekulargewicht: 700.90
• Reinheit: 99.30
• CAS Nummer: [306776-79-4]
• Formel: C35H64N4O10
• Target-Kategorie: Radionuclide-Drug Conjugates (RDCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound